Top Menu

Noticeboard: HammondCare director to head global body

In this story:

  • HammondCare clinical director to head international body
  • Matt Durston appointed Allocate ANZ manager

HammondCare clinical director to head international body

Aged care provider HammondCare has welcomed the appointment of its senior staff specialist Dr Friedbert Kohler as president of the International Society for Prosthetics and Orthotics (ISPO).

Friedbert Kohler

ISPO is a global non-governmental organisation aiming to improve the quality of life for people who need prosthetic, mobility and assistive devices. It works closely with the World Health Organization advising on education, research and issues.

HammondCare said Dr Kohler’s appointment is a reflection of the high regard in which he is held as a leader in rehabilitation and assistive technology.

Dr Kohler said during his two-year appointment he planned to champion the needs of the people who were dependant on assistive technology, in particular prosthetics and orthotics but could not afford or source them.

Dr Kohler is the director of medical services, Braeside Hospital and the clinical director of aged care and rehabilitation in Sydney’s south-west.

Matt Durston appointed Allocate ANZ manager

Matt Durston

Allocate Software, a leading provider of healthcare workforce management software, has appointed Matt Durston as its new general manager for Australia and New Zealand.

Mr Durston will manage business operations, sales, professional services and support for Australia and New Zealand, the company said.

He has been with Allocate Software for 13 years, most recently in the role of account director for New South Wales Health, managing Allocate’s partnership in the state-wide rollout of HealthRoster. Once completed, this project will roster and pay 115,000 employees across all staff groups in NSW Health.

Previously Mr Durston had senior roles leading parts of the Allocate business in the UK.

Have we missed an appointment? Send us the details and an image to

, , ,

, , , ,

No comments yet.

Leave a Reply